Literature DB >> 26980490

Tuberculosis as a three-act play: A new paradigm for the pathogenesis of pulmonary tuberculosis.

Robert L Hunter1.   

Abstract

Lack of access to human tissues with untreated tuberculosis (TB) has forced generations of researchers to use animal models and to adopt a paradigm that granulomas are the characteristic lesion of both primary and post primary TB. An extended search of studies of human lung tissues failed to find any reports that support this paradigm. We found scores of publications from gross pathology in 1804 through high resolution CT scans in 2015 that identify obstructive lobular pneumonia, not granulomas, as the characteristic lesion of developing post-primary TB. This paper reviews this literature together with other relevant observations to formulate a new paradigm of TB with three distinct stages: a three-act play. First, primary TB, a war of attrition, begins with infection that spreads via lymphatics and blood stream before inducing systemic immunity that contains and controls the organisms within granulomas. Second, post-primary TB, a sneak attack, develops during latent TB as an asymptomatic obstructive lobular pneumonia in persons with effective systemic immunity. It is a paucibacillary process with no granulomas that spreads via bronchi and accumulates mycobacterial antigens and host lipids for 1-2 years before suddenly undergoing caseous necrosis. Third, the fallout, is responsible for nearly all clinical post primary disease. It begins with caseous necrotic pneumonia that is either retained to become the focus of fibrocaseous disease or is coughed out to leave a cavity. This three-stage paradigm suggests testable hypotheses and plausible answers to long standing questions of immunity to TB.
Copyright © 2015 The Author. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Cavity; Human; Lung; Pathogenesis; Pathology; Post primary

Mesh:

Substances:

Year:  2016        PMID: 26980490      PMCID: PMC4795183          DOI: 10.1016/j.tube.2015.11.010

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  64 in total

1.  Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment.

Authors:  A van Rie; R Warren; M Richardson; T C Victor; R P Gie; D A Enarson; N Beyers; P D van Helden
Journal:  N Engl J Med       Date:  1999-10-14       Impact factor: 91.245

2.  Pathology of the Tuberculosis of Childhood and Its Bearing on Clinical Work.

Authors:  E L Opie
Journal:  Br Med J       Date:  1927-12-17

3.  Selective Localization of Pulmonary Emboli: An Explanation for the Apical Localization of Reinfection Tuberculosis.

Authors:  D T Smith; R S Abernathy
Journal:  Trans Am Clin Climatol Assoc       Date:  1949

Review 4.  Imaging in tuberculosis.

Authors:  Evangelia Skoura; Alimuddin Zumla; Jamshed Bomanji
Journal:  Int J Infect Dis       Date:  2015-03       Impact factor: 3.623

5.  Reproducibility of registration-based measures of lung tissue expansion.

Authors:  Kaifang Du; John E Bayouth; Kunlin Cao; Gary E Christensen; Kai Ding; Joseph M Reinhardt
Journal:  Med Phys       Date:  2012-03       Impact factor: 4.071

6.  Mycobacterium tuberculosis dysregulates MMP/TIMP balance to drive rapid cavitation and unrestrained bacterial proliferation.

Authors:  André Kübler; Brian Luna; Christer Larsson; Nicole C Ammerman; Bruno B Andrade; Marlene Orandle; Kevin W Bock; Ziyue Xu; Ulas Bagci; Daniel J Mollura; John Marshall; Jay Burns; Kathryn Winglee; Bintou Ahmadou Ahidjo; Laurene S Cheung; Mariah Klunk; Sanjay K Jain; Nathella Pavan Kumar; Subash Babu; Alan Sher; Jon S Friedland; Paul T G Elkington; William R Bishai
Journal:  J Pathol       Date:  2014-10-06       Impact factor: 7.996

Review 7.  Release of mycobacterial antigens.

Authors:  Laleh Majlessi; Rafael Prados-Rosales; Arturo Casadevall; Roland Brosch
Journal:  Immunol Rev       Date:  2015-03       Impact factor: 12.988

Review 8.  Multiple roles of cord factor in the pathogenesis of primary, secondary, and cavitary tuberculosis, including a revised description of the pathology of secondary disease.

Authors:  Robert L Hunter; Margaret R Olsen; Chinnaswamy Jagannath; Jeffrey K Actor
Journal:  Ann Clin Lab Sci       Date:  2006       Impact factor: 1.256

9.  Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved.

Authors:  Iñaki Comas; Jaidip Chakravartti; Peter M Small; James Galagan; Stefan Niemann; Kristin Kremer; Joel D Ernst; Sebastien Gagneux
Journal:  Nat Genet       Date:  2010-05-23       Impact factor: 38.330

10.  High prevalence of tuberculosis in previously treated patients, Cape Town, South Africa.

Authors:  Saskia den Boon; Schalk W P van Lill; Martien W Borgdorff; Donald A Enarson; Suzanne Verver; Eric D Bateman; Elvis Irusen; Carl J Lombard; Neil W White; Christine de Villiers; Nulda Beyers
Journal:  Emerg Infect Dis       Date:  2007-08       Impact factor: 6.883

View more
  51 in total

1.  Aminoglycoside-induced Hearing Loss Among Patients Being Treated for Drug-resistant Tuberculosis in South Africa: A Prediction Model.

Authors:  Hyejeong Hong; David W Dowdy; Kelly E Dooley; Howard W Francis; Chakra Budhathoki; Hae-Ra Han; Jason E Farley
Journal:  Clin Infect Dis       Date:  2020-02-14       Impact factor: 9.079

2.  Mechanisms of mycobacterial transmission: how does Mycobacterium tuberculosis enter and escape from the human host.

Authors:  Michael U Shiloh
Journal:  Future Microbiol       Date:  2016-11-10       Impact factor: 3.165

Review 3.  Tuberculosis vaccines - perspectives from the NIH/NIAID Mycobacteria vaccine testing program.

Authors:  Angelo A Izzo
Journal:  Curr Opin Immunol       Date:  2017-07-24       Impact factor: 7.486

Review 4.  Extracellular matrix as a driver of progressive fibrosis.

Authors:  Jeremy Herrera; Craig A Henke; Peter B Bitterman
Journal:  J Clin Invest       Date:  2018-01-02       Impact factor: 14.808

5.  Extensive Multisystemic Disseminated Tuberculosis in an Immunocompetent Patient.

Authors:  Amrit Kaur; Monika Kucheria; Rekha Gupta; Gurvinder Pal Thami; Reetu Kundu
Journal:  J Clin Aesthet Dermatol       Date:  2018-09-01

6.  Host-pathogen redox dynamics modulate Mycobacterium tuberculosis pathogenesis.

Authors:  Hayden T Pacl; Vineel P Reddy; Vikram Saini; Krishna C Chinta; Adrie J C Steyn
Journal:  Pathog Dis       Date:  2018-07-01       Impact factor: 3.166

7.  Multi-scale models of lung fibrosis.

Authors:  Julie Leonard-Duke; Stephanie Evans; Riley T Hannan; Thomas H Barker; Jason H T Bates; Catherine A Bonham; Bethany B Moore; Denise E Kirschner; Shayn M Peirce
Journal:  Matrix Biol       Date:  2020-05-11       Impact factor: 11.583

8.  Hypervirulent Mycobacterium tuberculosis strain triggers necrotic lung pathology associated with enhanced recruitment of neutrophils in resistant C57BL/6 mice.

Authors:  Fabrício M Almeida; Thatiana L B Ventura; Eduardo P Amaral; Simone C M Ribeiro; Sanderson D Calixto; Marcelle R Manhães; Andreza L Rezende; Giliane S Souza; Igor S de Carvalho; Elisangela C Silva; Juliana Azevedo da Silva; Eulógio C Q Carvalho; Afranio L Kritski; Elena B Lasunskaia
Journal:  PLoS One       Date:  2017-03-17       Impact factor: 3.240

9.  Reconsidering the Optimal Immune Response to Mycobacterium tuberculosis.

Authors:  Liku B Tezera; Salah Mansour; Paul Elkington
Journal:  Am J Respir Crit Care Med       Date:  2020-02-15       Impact factor: 21.405

Review 10.  Caseum: a Niche for Mycobacterium tuberculosis Drug-Tolerant Persisters.

Authors:  Jansy P Sarathy; Véronique Dartois
Journal:  Clin Microbiol Rev       Date:  2020-04-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.